Table. 1.

Table. 1.

Peritransplant clinical profiles of seven patients

Case no. Sex Age at LT (mon) Body weight at LT (kg) Total bilirubin (mg/dL) Direct bilirubin (mg/dL) PT INR AFP (ng/mL) PFIC type Donor Graft type Graft weight (g) GRWR (%) Graft survival period (mon) Patient survival period (mon) Post transplant status
1 F 3 4.1 26.1 16.4 2.01 NA 2 DD HRLLS 225 5.5 96 96 Alive
2 F 7 7.2 23.8 19.8 2.09 2,740 2 Mother LLS 216 3.1 91 91 Alive
3 F 18 8.5 21.6 19.3 1.11 0.9 1 DD LLS 370 4.4 39 86 Alive after retransplant
4 F 3 4.9 12.4 8.3 1.62 80,600 2 Mother HRLLS 120 2.5 84 84 Alive
5 F 14 9.3 14.5 10.5 1.91 11,072 2 Mother LLS 275 3.1 81 81 Alive
6 M 10 6.3 10.4 9.4 1.53 NA 1 DD WL 245 4.1 35 35 Dead
7 M 46 12.2 3.8 3.3 1.19 NA 2 Mother LLS 285 2.4 11 11 Alive

F, female; M, male; LT, liver transplantation; PT INR, prothrombin time international normalized ratio; AFP, alpha-fetoprotein; PFIC, progressive familial intrahepatic cholestasis; GRWR, graft-to-recipient weight ratio; NA, not available; DD, deceased donor; HRLLS, hyper-reduced left lateral section; LLS, left lateral section; WL, whole liver.

Ann Hepatobiliary Pancreat Surg 2022;26:69-75 https://doi.org/10.14701/ahbps.21-114
© 2021 Ann Hepatobiliary Pancreat Surg